Back
Structure Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
4
GPCR
Structure Therapeutics
Last Price:
$19.58
Seasonality Move:
32.88%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
Structure Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.47 | Sell |
20-day SMA: | 20.69 | Sell |
50-day SMA: | 22.71 | Sell |
200-day SMA: | 27.58 | Sell |
8-day EMA: | 12.02 | Buy |
20-day EMA: | 6.25 | Buy |
50-day EMA: | 2.8 | Buy |
200-day EMA: | 0.74 | Buy |
Structure Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.22 | Buy |
Relative Strength Index (14 RSI): | 33.95 | Sell |
Chaikin Money Flow: | -195256 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.7 - 22.02) | Sell |
Bollinger Bands (100): | (18.77 - 24.53) | Sell |
Structure Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 19.01 while GPCR 8-day simple moving average is 19.47, which is a Sell signal.
-
The stock price of GPCR is 19.01 while Structure Therapeutics 20-day SMA is 20.69, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 22.71 while GPCR share price is 19.01, making it a Sell technically.
-
GPCR stock price is 19.01 and Structure Therapeutics 200-day simple moving average is 27.58, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
4
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $19.01. The Score for GPCR is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.1B
Price in USD:
19.01
Share Volume:
685.9K
Structure Therapeutics 52-Week Range
52-Week High:
47.48
52-Week Low:
13.22
Sell
4
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 19.01 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 19.01 while GPCR 8-day exponential moving average is 12.02, which is a Buy signal.
-
The stock price of GPCR is 19.01 while Structure Therapeutics 20-day EMA is 6.25, which makes it a Buy.
-
Structure Therapeutics 50-day exponential moving average is 2.80 while GPCR share price is 19.01, making it a Buy technically.
-
GPCR stock price is 19.01 and Structure Therapeutics 200-day simple moving average is 0.74, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.77 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 4.22, suggesting Structure Therapeutics is a Buy
-
Structure Therapeutics Relative Strength Index (RSI) is 33.95, which suggest Structure Therapeutics is oversold
-
The Bollinger Bands (25) for Structure Therapeutics is (19.7 - 22.02), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (18.77 - 24.53), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.